Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH) E10: €0.11 (As of Mar. 2026)


STU:08HH Shanghai Fosun Pharmaceutical (Group) Co Ltd STU:08HH
73 GF Score
Price €1.67
GF Value €1.96
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Shanghai Fosun Pharmaceutical (Group) Co E10?

Shanghai Fosun Pharmaceutical (Group) Co STU:08HH -4.08% 73 E10 is €0.11 as of Mar. 2026. GuruFocus rates STU:08HH with a GF Score™ of 73/100 and a GF Value™ of €1.96 (Modestly Undervalued). The stock has 10 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Shanghai Fosun Pharmaceutical (Group) Co's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.041. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.11 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Shanghai Fosun Pharmaceutical (Group) Co's average E10 Growth Rate was 1.50% per year. During the past 5 years, the average E10 Growth Rate was 2.40% per year. During the past 10 years, the average E10 Growth Rate was 5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Shanghai Fosun Pharmaceutical (Group) Co was 15.90% per year. The lowest was 0.00% per year. And the median was 9.65% per year.

As of today (2026-07-01), Shanghai Fosun Pharmaceutical (Group) Co's current stock price is €1.6695. Shanghai Fosun Pharmaceutical (Group) Co's E10 for the quarter that ended in Mar. 2026 was €0.11. Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio of today is 15.18.

During the past 13 years, the highest Shiller PE Ratio of Shanghai Fosun Pharmaceutical (Group) Co was 68.81. The lowest was 15.83. And the median was 26.58.


Shanghai Fosun Pharmaceutical (Group) Co  (STU:08HH) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Shanghai Fosun Pharmaceutical (Group) Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1.6695/0.11
=15.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Shanghai Fosun Pharmaceutical (Group) Co was 68.81. The lowest was 15.83. And the median was 26.58.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Shanghai Fosun Pharmaceutical (Group) Co E10 Related Terms


Shanghai Fosun Pharmaceutical (Group) Co E10 Historical Data

* Premium members only.

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Fosun Pharmaceutical (Group) Co E10 Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.11 0.10 0.09 0.11

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.09 0.12 0.11 0.11

STU:08HH vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Fosun Pharmaceutical (Group) Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio falls into.


STU:08HH
73GF Score
Shanghai Fosun Pharmaceutical (Group) Co Ltd STU:08HH
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Fosun Pharmaceutical (Group) Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shanghai Fosun Pharmaceutical (Group) Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.041/116.3033*116.3033
=0.041

Current CPI (Mar. 2026) = 116.3033.

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.051 101.400 0.058
201609 0.039 102.400 0.044
201612 0.036 102.600 0.041
201703 0.042 103.200 0.047
201706 0.050 103.100 0.056
201709 0.037 104.100 0.041
201712 0.036 104.500 0.040
201803 0.036 105.300 0.040
201806 0.046 104.900 0.051
201809 0.025 106.600 0.027
201812 0.031 106.500 0.034
201903 0.037 107.700 0.040
201906 0.040 107.700 0.043
201909 0.028 109.800 0.030
201912 0.063 111.200 0.066
202003 0.030 112.300 0.031
202006 0.055 110.400 0.058
202009 0.037 111.700 0.039
202012 0.058 111.500 0.060
202103 0.043 112.662 0.044
202106 0.083 111.769 0.086
202109 0.055 112.215 0.057
202112 0.064 113.108 0.066
202203 0.026 114.335 0.026
202206 0.059 114.558 0.060
202209 0.049 115.339 0.049
202212 0.066 115.116 0.067
202303 0.050 115.116 0.051
202306 0.039 114.558 0.040
202309 0.023 115.339 0.023
202312 0.004 114.781 0.004
202403 0.029 115.227 0.029
202406 0.029 114.781 0.029
202409 0.037 115.785 0.037
202412 0.038 114.893 0.038
202503 0.037 115.116 0.037
202506 0.042 114.907 0.043
202509 0.037 115.471 0.037
202512 0.039 115.832 0.039
202603 0.041 116.303 0.041

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.11 mean?
Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH) has a E10 of €0.11 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Shanghai Fosun Pharmaceutical (Group) Co and its competitors.
Is Shanghai Fosun Pharmaceutical (Group) Co's E10 too high?
Shanghai Fosun Pharmaceutical (Group) Co's current E10 is €0.11. Overall, Shanghai Fosun Pharmaceutical (Group) Co has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Fosun Pharmaceutical (Group) Co's E10 compare to ZTS and UTHR?
Shanghai Fosun Pharmaceutical (Group) Co's E10 of €0.11 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Shanghai Fosun Pharmaceutical (Group) Co and its competitors. Shanghai Fosun Pharmaceutical (Group) Co's current E10 is €0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Fosun Pharmaceutical (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH) is currently considered Modestly Undervalued. The stock's GF Value™ is €1.96, compared to a current price of €1.67 — trading 14.8% below its estimated fair value. The current E10 is €0.11. Shanghai Fosun Pharmaceutical (Group) Co's overall GF Score™ is 73/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH), the current E10 is €0.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Fosun Pharmaceutical (Group) Co stock appears to be undervalued. The current stock price of €1.67 is trading 14.8% below its estimated GF Value™ of €1.96. GuruFocus considers Shanghai Fosun Pharmaceutical (Group) Co to be Modestly Undervalued.

Key valuation signals for STU:08HH:

  • E10: €0.11
  • GF Value™: €1.96 vs. price of €1.67 (14.8% below fair value)
  • GF Score™: 73/100 with 10 warning signs

No single metric tells the full story. See the STU:08HH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Fosun Pharmaceutical (Group) Co Business Description

Address No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233
Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers mergers and acquisitions as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.
73GF Score

Get the complete analysis for STU:08HH

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.67
Price
€1.96
GF Value